Statin therapy appears to reduce incidence of venous thromboembolism in secondary analyses of nonvenous thrombembolism trials. In this video AJM Editor-in Chief Joseph S. Alpert, MD, discusses new population research that shows statin presciption reduced risk of venous thromboembolism recurrence by approximately 25%.
You can read “Statin Use Is Associated with Reduced Risk of Recurrence in Patients with Venous Thromboembolism” in the August 2020 issue of the American Journal of Medicine at amjmed.com.
